All News

Fibromyalgianess Influences Steroid Persistence

Save

d Jack Cush, MD

Jul 30, 2021

"Fibromyalgianess" is highlighted as a risk factor for undue, extended glucocorticoid use in rheumatoid arthritis (RA) patients, according to Wallace and colleagues in Rheumatology.

Read Article

RheumNow Podcast – Psoriatic Arthritis Without Psoriasis (7.30.2021)

Save

d Jack Cush, MD

Jul 30, 2021

How much psoriasis do you need to have in order to have psoriatic arthritis? This plus a review of rheumatology and COVID news from the past week on RheumNow.com.

Read Article

Shingles Risk with JAK Inhibitors and Other Biologics

Save

d Jack Cush, MD

Jul 29, 2021

Registry data suggests an increased risk of herpes zoster (HZ, shingles) in rheumatoid arthritis (RA) patients taking JAK inhibitors (JAKi) but also with other biologic DMARDs, compared to csDMARDs.

Read Article

Registry data suggests an increased risk of herpes zoster (HZ, shingles) in rheumatoid arthritis (RA) patients taking JAK inhibitors (JAKi) but also with other biologic DMARDs, compared to csDMARDs. https://t.co/Uu1VjAbKMi https://t.co/uGvTyLExjf

Links:

https://bit.ly/3ifPwMu

Dr. John Cush RheumNow ( View Tweet)

Aug 02, 2021

The ARTIS Study Group has published their analysis of (non-skin) cancer risk in rheumatoid arthritis, claiming the overall safety of biologic DMARDs and targeted synthetic DMARDs (tsDMARDs). https://t.co/RNWrLR53Wx https://t.co/mMmKKrX9vx

Links:

https://bit.ly/3j3iBcZ

Dr. John Cush RheumNow ( View Tweet)

Aug 02, 2021

Health personnel (HCP) @ long-term care facilities (LTCFs) are at high risk for COVID-19. March 2021, 57% of LTCF HCPs were vaccinated. COVID-19 vax was highest in MDs (75.1%); lowest nurses (56.7%) & aides (45.6%). https://t.co/VjHutcrh26 https://t.co/8aO1mFgC8f

Links:

https://bit.ly/3j54NPa

Dr. John Cush RheumNow ( View Tweet)

Aug 01, 2021

ICYMI: The FDA has authorized baricitinib ALONE as treatment for COVID-19 hospitalized adults and pediatric patients requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) https://t.co/WMc78GmOLU https://t.co/Bp5tL4pRk5

Links:

https://bit.ly/2UTEAv7

Dr. John Cush RheumNow ( View Tweet)

Aug 01, 2021

Worth another share-- Turning the Corner on CV Risk in Rheumatoid Arthritis by Richard Conway ( @RichardPAConway) #EULAR2021 https://t.co/S0ownscRKv https://t.co/7QtynRKAd6

Links:

https://bit.ly/34KzliI

Dr. John Cush RheumNow ( View Tweet)

Aug 01, 2021

ICYMI: One of our top June videos WATCH: Is blindness with Tocilizumab in GCA a worry? Dr. David Liew ( @drdavidliew ) weighs in. #EULAR2021 https://t.co/eFrmbkW9Gy https://t.co/4tY3hEDj2j

Links:

https://bit.ly/3jKRCoA

Dr. John Cush RheumNow ( View Tweet)

Aug 01, 2021

Pain Persists in RA, Even Without Inflammation One-third of patients with rheumatoid arthritis had unacceptably high levels of pain 5 years after diagnosis, often despite low levels of inflammation, Swedish researchers found. https://t.co/K8zf1pE9jM https://t.co/aEBu7jVHft

Links:

https://bit.ly/3vM6PZ3

Dr. John Cush RheumNow ( View Tweet)

Jul 31, 2021

RheumNow Podcast – Psoriatic Arthritis Without Psoriasis Download wherever you get your podcasts! https://t.co/Ra5f7507XT https://t.co/5WqPCgGVpr

Links:

https://bit.ly/3rPXI9d

Dr. John Cush RheumNow ( View Tweet)

Jul 31, 2021

Did you see this tweet from May? Worth re-sharing. Rituximab Tops Mycophenolate Mofetil for Pemphigus Vulgaris. One year study of 135 moderate-to-severe pemphigus patients saw complete remission in 40% of RTX vs 10% of MMF patients. https://t.co/yAauFRjHCe https://t.co/bibHXaHtWf

Links:

https://bit.ly/33YZ1HS

Dr. John Cush RheumNow ( View Tweet)

Jul 31, 2021

ICYMI: Belimumab now approved in the EU for lupus nephritis. The EMA has approved intravenous and subcutaneous Benlysta (belimumab) in combination with background immunosuppressive therapies for adults with active lupus nephritis https://t.co/Twbe1ClT5w

Links:

https://bit.ly/3ekjKM7

Dr. John Cush RheumNow ( View Tweet)

Jul 31, 2021

New podcast available for download! We focus on the articles shared this week on https://t.co/V10S4oVFsv . https://t.co/Ra5f7507XT https://t.co/Pz0RFxLIOx

Links:

Dr. John Cush RheumNow ( View Tweet)

Jul 30, 2021

Swiss SCQM registry compared 3217 RA & 819 PsA pts; PsA had more obese (36.5% overweight, 23.8% obese) than RA (4.4% underweight, 31.8% overweight, 17.0% obese). Obese PsA had higher CRP, Dz activity, worse QOL, pain & skin https://t.co/UzbKlT3tSz

Links:

https://bit.ly/2Vkozhk

Dr. John Cush RheumNow ( View Tweet)

Jul 30, 2021

Literature review examined safety of IL-17 inhibitors in 106 controlled RCTs, 40,053 pts. Inflammatory bowel disease was reported in 0.4% of IL-17i Rx patients. (same in 61 uncontrolled RCTs -0.36%). Other AE: diarrhea (2.5%), N/V(0.7%) https://t.co/2wSZQqB1Zs

Links:

https://bit.ly/3j1yT6b

Dr. John Cush RheumNow ( View Tweet)

Jul 30, 2021

JAMA article on using new features in Updated PubMed: 1) Focus the Clinical Question 2) Use PubMed Clinical Query Filters 3) Refine the Search Terms https://t.co/ExK8p2hVnX

Links:

https://bit.ly/3le8958

Dr. John Cush RheumNow ( View Tweet)

Jul 30, 2021

Comparison of 1040 elderly-onset RA (EORA) and 710 non-EORA patients showed similar disease activity, DMARD choices, drug response rates and reasons for Rx discontinuation - There's no reason EORA shouldn't be treated as aggressive as all RA! https://t.co/P2gpPlJVZE

Links:

https://bit.ly/3iYQNqh

Dr. John Cush RheumNow ( View Tweet)

Jul 30, 2021

ICYMI: Drugs capable of inducing drug-associated ANCA vasculitis - mirabegron (Myrbetriq), sofosbuvir (Sovaldi, antiviral), nintedanib (Ofev), hydralazine, propylthiouracil, thiamazole, minocycline, carbimazole, allopurinol, influenza vax.... https://t.co/KhK2w0IGAx

Links: